Severn Trent PLC (OTCMKTS:STRNY – Get Free Report) has earned a consensus recommendation of “Hold” from the six brokerages that are presently covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation.
STRNY has been the subject of several research analyst reports. Royal Bank Of Canada reissued a “sector perform” rating on shares of Severn Trent in a report on Monday, June 1st. Zacks Research raised shares of Severn Trent from a “strong sell” rating to a “hold” rating in a report on Friday, June 12th. BNP Paribas Exane initiated coverage on shares of Severn Trent in a research report on Monday, June 29th. They issued a “neutral” rating for the company. Citigroup reiterated a “neutral” rating on shares of Severn Trent in a research note on Thursday, June 11th. Finally, Jefferies Financial Group downgraded shares of Severn Trent from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 3rd.
View Our Latest Report on STRNY
Severn Trent Stock Performance
About Severn Trent
Severn Trent Plc (OTCMKTS:STRNY) is an integrated water utility company based in Coventry, United Kingdom, specializing in the provision of water supply and wastewater treatment services. As one of the principal regulated water and sewerage companies in England and Wales, it delivers clean drinking water to households and businesses, manages sewer networks, operates sewage treatment works, and maintains extensive water infrastructure across its service regions. Its operations are governed by regulatory frameworks that aim to ensure high standards of water quality, environmental protection, and customer service.
The company traces its origins to the privatization of the regional water authorities in England and Wales in 1989.
Further Reading
- Five stocks we like better than Severn Trent
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Severn Trent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Severn Trent and related companies with MarketBeat.com's FREE daily email newsletter.
